We know that by working with these top-notch non-profit organizations and advocacy groups we can make a greater impact on the lives of mesothelioma patients and their families.
Whether it’s helping to fight back in the medical battle against mesothelioma or the global fight against asbestos, we are proud to sponsor initiatives for the mesothelioma community. Here are some of the groups we have supported:
The Asbestos Disease Awareness Organization (ADAO) is an independent non-profit organization founded to fight mesothelioma by bringing attention to the need for innovative medial treatments and advocating for a global ban on asbestos.
Founded by mesothelioma widow Linda Reinstein and Doug Larkin, ADAO is a key organization in the global fight against asbestos. We have been a long-time sponsor of ADAO’s groundbreaking work and are proud to be a 2012 and 2013 platinum-level sponsor.
Russell Budd, our firm’s president and managing shareholder, formerly served on the NCCN Foundation Board, the philanthropic arm of the NCCN.
Seeing the need for patient-centric materials about mesothelioma, Baron & Budd sponsored the creation of the NCCN Patient Guidelines for Mesothelioma. Translated from the NCCN Clinical Guidelines, the mesothelioma patient guidelines offer a step-by-step guide to understanding this cancer, including how to navigate treatment options and communicate effectively with medical professionals.
Baron & Budd provided the cornerstone donation that helped Dr. David Sugarbaker establish the now renowned International Mesothelioma Program (IMP) at Brigham and Women’s Hospital in Boston. This program offers cutting-edge treatments for people suffering from pleural mesothelioma. The mission of IMP is to develop effective medications and treatments for mesothelioma, as well as researching new screening tools to help physicians detect mesothelioma earlier.
CURE media group, the publishers of CURE magazine, is dedicated to providing patient-friendly information about cancer to families, patients and caregivers throughout their cancer journey. Because mesothelioma is so rare, it can be difficult for patients to find accessible material, so we partnered with CURE to publish the book Understanding Mesothelioma.